Advertisement

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

First International Summit on Interventional Pharmacoeconomics

Advertisement

Related Videos

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Deborah Collyar: What's In It for Patients?

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Opening Session Panel Discussion

Advertisement

Advertisement

Jul

22

Today In Oncology

Can Consolidative Thoracic Radiotherapy Improve Outcomes During Immunotherapy Maintenance in Extensive-Stage SCLC?

Early Research Examines Daraxonrasib in NRAS-Mutant Melanoma

Treatment Delays May Increase Metastasis Risk in Nonmetastatic Colorectal Cancer

Integrating Environmental Health Into Pediatric Cancer Care May Improve Outcomes

Emergency Department Cancer Diagnosis Associated With Higher Mortality Across 16 Cancer Types

Advertisement

© 2026 HSP News Service, L.L.C.